FDA Inspection 806438 — Gregory Pharmaceutical Holdings Inc.

Gregory Pharmaceutical Holdings Inc. — FEI 1000208638

The FDA completed an inspection of Gregory Pharmaceutical Holdings Inc. on November 13, 2012 in Bristol, TN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 13, 2012
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bristol, TN (United States)